APOSAN

Koln, Germany Acquired By IK Partners
Rehabilitation services are provided to patients in Cologne, Germany.
Request Access

About APOSAN

APOSAN is a company based in Koln (Germany) was acquired by IK Partners in October 2016. It operates as a Managed Services, and HealthTech. APOSAN offers products and services including Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition.

  • Headquarter Koln, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aposan Gmbh
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    IK Partners

    (Oct 05, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of APOSAN

APOSAN offers a comprehensive portfolio of products and services, including Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Parenteral antibiotic therapy is provided for home use.

Customized nutritional infusions are prepared for home therapy.

Nutritional support is offered through enteral feeding solutions.

Funding Insights of APOSAN

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in APOSAN

APOSAN has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IK Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are directed toward small and medium-sized businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by APOSAN

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - APOSAN

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aposan Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of APOSAN

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aposan

Frequently Asked Questions about APOSAN

Where is APOSAN located?

APOSAN is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

What does APOSAN do?

APOSAN is focused on delivering ambulatory medication therapies tailored for home application. Specialized solutions are provided in areas such as parenteral antibiotic therapy, parenteral and enteral nutrition, and treatments for conditions like age-related macular degeneration and cystic fibrosis. Services are extended to patients, healthcare providers, hospitals, pharmacies, and care facilities across Germany. Comprehensive patient care and support are ensured to enable independent therapy management in familiar surroundings. The company operates within the healthcare sector, emphasizing personalized infusion solutions and holistic care concepts.

What products or services does APOSAN offer?

APOSAN offers Ambulatory Parenteral Antibiotic Therapy (APAT), Parenteral Nutrition, and Enteral Nutrition.

Who are APOSAN's investors?

APOSAN has 1 investor. Key investors include IK Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available